DD Mostly mechanistic or early data. Shown openly. How we grade →Single-arm pilot · 20 patients
Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition
A Smith, I Choi, P Lee, D Sullivan, J Burns, R Swerdlow et al. Alzheimer's & Dementia: Translational Research & Clinical Interventions. 2025.
- In plain language
- 20 g a day for 8 weeks was feasible in Alzheimer's disease, raised brain creatine by 11% and was followed by better scores on some tests; 13 mild side effects.
- Limits
- No placebo group, so it cannot show efficacy; creatine donated by Life Extension.
- Which of our grades it feeds
- CC Small or few human trials. Promising, not proven. How we grade →Science summary: Creatine and the brain: memory, thinking and sleep loss, and why a regulator said not proven
- Source
- doi.org/10.1002/trc2.70101 · PubMed 40395689 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.